Developing novel antibodies for cancer and other diseases.
Industry: Health Care
First Day Return: +2.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/28/2019 |
Offer Price | $17.75 |
Price Range $17.75 - $17.75 | |
Offer Shares (mm) | 28.5 |
Deal Size ($mm) | $506 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/17/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $506 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Copenhagen, Denmark |
Founded | 1998 |
Employees at IPO | 419 |
Website www.genmab.com |